The advertisement promotes VYVGART and VYVGART Hybrid as potential add-on treatments for adult patients with anti-AChR antibody positive generalized Myasthenia Gravis (gMG) who are experiencing difficulties with symptom management.
Creative Information
| CID: | 4348a594-115f-49ba-bf7b-1d2c6544fc9e |
| CRID: | 82_5970-949149 |
| Domain: | vyvgarthcp.com |
| Seat: | PP |
| Size: | 728x90 |
| Bid: | $1.08 |
| Timestamp: | 10/31/2025, 5:55:12 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 10/31/2025, 6:51:48 PM | 7.07s | |
| adomain_analysis | success | 10/31/2025, 8:26:00 PM | 2.87s | |
| adomain_capture | success | 10/31/2025, 8:25:22 PM | 0.08s | |
| ad_render | success | 10/31/2025, 6:51:41 PM | 26.67s | |
| brand_mapping | success | 10/31/2025, 5:55:13 PM | 0.09s | |
Analysis Results
Ad Format: banner
Brands: VYVGART Hytrulo
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 728x90 | ||||||||||||||||||||||
| Data Transferred: | 1139.98 KB | ||||||||||||||||||||||
| Render Time: | 10.84 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1140.06 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives

